Both Tebuconazole and Prochloraz belong to FRAC Group 3; they interfere with the normal formation of the fungal cell membrane by inhibiting the C14 demethylation step in the sterol biosynthesis pathway of pathogenic fungi.
As the two active ingredients belong to different DMI chemical classes, there may be differences in their activity against certain pathogens and in their application characteristics.
This combination product may be selected as a formulation for specific fungal diseases to which the pathogens are susceptible; however, it should be noted that both active ingredients share the same primary mode of action.
Consequently, Tebuconazole + Prochloraz cannot be regarded as a resistance management combination comprising two different FRAC Groups. Particular attention must be paid to the risk of cross-resistance in the case of pathogens that have already exhibited reduced sensitivity to DMIs.
As EW stands for emulsifiable concentrate, when procuring this product, one should also verify the emulsion stability, particle size and formulation quality under various storage conditions.
Supply Information
MaFa Agro provides supply consultancy for Tebuconazole 15% + Prochloraz 30% EW and can coordinate packaging specifications and labelling solutions to meet customer requirements.
We assist importers in verifying formulation parameters, quality documentation and procurement requirements for their target markets.